Posts With Tag NYSE EBS

Showing 1 - 3 of 3 Posts

Emergent Biosolutions Inc. 8-K Report: Key Updates as of January 15, 2025

$EBS

•

Form 8-K

•

2025-01-15

Last updated: 4 months ago

Emergent Biosolutions Inc. 8-K Report: Key Updates as of January 15, 2025

Discover Emergent Biosolutions Inc.'s latest 8-K filing. Stay informed on significant corporate changes impacting stock performance. Ticker: EBS, NYSE.

Emergent Biosolutions biopharmaceutical NYSE EBS corporate reporting financial disclosure

Emergent BioSolutions Inc. 8-K Filing Insights: Key Updates from January 14, 2025

$EBS

•

Form 8-K

•

2025-01-14

Last updated: 4 months ago

Emergent BioSolutions Inc. 8-K Filing Insights: Key Updates from January 14, 2025

Explore Emergent BioSolutions Inc.'s 8-K report detailing significant corporate changes as of January 14, 2025. Stay informed on stock performance and industry impacts.

Emergent BioSolutions Biotechnology NYSE EBS 8-K Filing Corporate Events

Emergent BioSolutions Inc. 8-K Report: Key Updates & Insights for Investors

$EBS

•

Form 8-K

•

2025-01-08

Last updated: 4 months ago

Emergent BioSolutions Inc. 8-K Report: Key Updates & Insights for Investors

Explore Emergent BioSolutions Inc.'s 8-K report filed on December 12, 2024, detailing significant corporate events. Stay informed about EBS stock and financial transparency.

Emergent BioSolutions biotechnology NYSE EBS financial reporting XBRL